193 related articles for article (PubMed ID: 10801821)
1. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
Wang W; Nagashima M; Schneider M; Morser J; Nesheim M
J Biol Chem; 2000 Jul; 275(30):22942-7. PubMed ID: 10801821
[TBL] [Abstract][Full Text] [Related]
2. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
Kokame K; Zheng X; Sadler JE
J Biol Chem; 1998 May; 273(20):12135-9. PubMed ID: 9575159
[TBL] [Abstract][Full Text] [Related]
3. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
[TBL] [Abstract][Full Text] [Related]
4. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
Hall SW; Nagashima M; Zhao L; Morser J; Leung LL
J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282
[TBL] [Abstract][Full Text] [Related]
5. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
Bajzar L; Nesheim M; Morser J; Tracy PB
J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
[TBL] [Abstract][Full Text] [Related]
6. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
[TBL] [Abstract][Full Text] [Related]
7. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
[TBL] [Abstract][Full Text] [Related]
8. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
[TBL] [Abstract][Full Text] [Related]
9. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity.
Nagashima M; Lundh E; Leonard JC; Morser J; Parkinson JF
J Biol Chem; 1993 Feb; 268(4):2888-92. PubMed ID: 8381415
[TBL] [Abstract][Full Text] [Related]
10. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation.
Incampo F; Carrieri C; Semeraro N; Colucci M
Thromb Res; 2014 Nov; 134(5):1110-6. PubMed ID: 25193406
[TBL] [Abstract][Full Text] [Related]
11. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
Boffa MB; Wang W; Bajzar L; Nesheim ME
J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
[TBL] [Abstract][Full Text] [Related]
12. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
Marar TT; Boffa MB
J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
[TBL] [Abstract][Full Text] [Related]
13. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI.
Roussel JC; Moran CJ; Salvaris EJ; Nandurkar HH; d'Apice AJ; Cowan PJ
Am J Transplant; 2008 Jun; 8(6):1101-12. PubMed ID: 18444940
[TBL] [Abstract][Full Text] [Related]
14. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
[TBL] [Abstract][Full Text] [Related]
15. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
Plug T; Marquart JA; Marx PF; Meijers JC
J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
[TBL] [Abstract][Full Text] [Related]
16. A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.
Okada M; Tominaga N; Honda G; Nishioka J; Akita N; Hayashi T; Suzuki K; Moriuchi H
Blood Adv; 2020 Jun; 4(12):2631-2639. PubMed ID: 32556284
[TBL] [Abstract][Full Text] [Related]
17. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
Mosnier LO
J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
[TBL] [Abstract][Full Text] [Related]
18. Structure-function studies of the epidermal growth factor domains of human thrombomodulin.
Parkinson JF; Nagashima M; Kuhn I; Leonard J; Morser J
Biochem Biophys Res Commun; 1992 Jun; 185(2):567-76. PubMed ID: 1319140
[TBL] [Abstract][Full Text] [Related]
19. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
Bajzar L; Nesheim ME; Tracy PB
Blood; 1996 Sep; 88(6):2093-100. PubMed ID: 8822928
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.
Marx PF; Hackeng TM; Dawson PE; Griffin JH; Meijers JC; Bouma BN
J Biol Chem; 2000 Apr; 275(17):12410-5. PubMed ID: 10777524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
